‘Disturbing’ variations in use of adjuvant tamoxifen Newsletter Article 06 February 2013 Pages: 3 - 3
Should cefalosporin use be prohibited in severe pneumonia? Newsletter Article 06 February 2013 Pages: 4 - 4
Guidelines for the treatment of children with HIV infection Newsletter Article 06 February 2013 Pages: 4 - 4
Targeting endothelial dysfunction in cardiovascular disease Newsletter Article 06 February 2013 Pages: 5 - 5
Persistence with lipid-lowering therapy in US and Canada Newsletter Article 06 February 2013 Pages: 6 - 6
Intranasal influenza virus vaccine effective in children Newsletter Article 06 February 2013 Pages: 9 - 9
Pneumococcal conjugate vaccine can be ‘safely administered’ Newsletter Article 06 February 2013 Pages: 10 - 10
Fomivirsen focuses on the future in CMV retinitis Sean Henahan Newsletter Article 06 February 2013 Pages: 11 - 12
Calcimimetic produces ‘dramatic effects’ in hyperparathyroidism Newsletter Article 06 February 2013 Pages: 12 - 12
IVIG plus azathioprine beneficial in relapsing-remitting MS Newsletter Article 06 February 2013 Pages: 13 - 13
Vitamins improve pregnancy outcomes in HIV-infected women Newsletter Article 06 February 2013 Pages: 13 - 13
Fractional doses of Hib vaccine immunogenic in Chilean infants Newsletter Article 06 February 2013 Pages: 14 - 14
Zolmitriptan zaps migraine in ‘real-life’ setting Larry Prescott Newsletter Article 06 February 2013 Pages: 15 - 16
‘Impressive’ results with indinavir regimen in children with HIV Newsletter Article 06 February 2013 Pages: 16 - 16
Single insulin injection ± glipizide for type 2 diabetes? Newsletter Article 06 February 2013 Pages: 19 - 19
Choosing between SSRIs and behaviour therapy in OCD Newsletter Article 06 February 2013 Pages: 19 - 19
Five drugs newly listed as known or likely human carcinogens Newsletter Article 06 February 2013 Pages: 21 - 21
Increase in worldwide cancer drug market predicted Newsletter Article 06 February 2013 Pages: 22 - 22